Latest News for EGRX
Eagle Pharmaceuticals (NASDAQ: EGRX - Get Free Report) and Indivior (OTCMKTS:INVVY - Get Free Report) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, dividends, risk, earnings, analyst recommendations, valuation and profitability. Analyst Ratings This is a breakdown of recent recommendations
Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.
Eagle Pharmaceuticals, Inc. (NASDAQ: EGRX - Get Free Report) shares passed above its 50-day moving average during trading on Monday. The stock has a 50-day moving average of $0.26 and traded as high as $0.3411. Eagle Pharmaceuticals shares last traded at $0.3411, with a volume of 104 shares. Eagle Pharmaceuticals Stock Performance The company has
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for EGRX.
U.S. House Trading
No House trades found for EGRX.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.